nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CA3—pericardium—sarcoma	0.016	0.0665	CbGeAlD
Zonisamide—SCN4B—myometrium—sarcoma	0.00618	0.0257	CbGeAlD
Zonisamide—CA2—periosteum—sarcoma	0.0056	0.0232	CbGeAlD
Zonisamide—SCN4B—seminal vesicle—sarcoma	0.00558	0.0232	CbGeAlD
Zonisamide—CA11—myometrium—sarcoma	0.00532	0.0221	CbGeAlD
Zonisamide—CA11—seminal vesicle—sarcoma	0.00481	0.02	CbGeAlD
Zonisamide—SCN3B—tendon—sarcoma	0.00413	0.0172	CbGeAlD
Zonisamide—SCN4B—cardiac atrium—sarcoma	0.00403	0.0167	CbGeAlD
Zonisamide—SCN1B—testis—sarcoma	0.00371	0.0154	CbGeAlD
Zonisamide—CA13—tendon—sarcoma	0.0036	0.015	CbGeAlD
Zonisamide—CA10—testis—sarcoma	0.00355	0.0148	CbGeAlD
Zonisamide—SCN4B—tendon—sarcoma	0.00351	0.0146	CbGeAlD
Zonisamide—SCN1B—liver—sarcoma	0.0035	0.0145	CbGeAlD
Zonisamide—CA8—testis—sarcoma	0.00348	0.0145	CbGeAlD
Zonisamide—CA11—cardiac atrium—sarcoma	0.00347	0.0144	CbGeAlD
Zonisamide—CA11—uterus—sarcoma	0.00345	0.0143	CbGeAlD
Zonisamide—SCN3B—testis—sarcoma	0.00342	0.0142	CbGeAlD
Zonisamide—CA3—myometrium—sarcoma	0.00325	0.0135	CbGeAlD
Zonisamide—CA11—tendon—sarcoma	0.00302	0.0126	CbGeAlD
Zonisamide—CA13—testis—sarcoma	0.00298	0.0124	CbGeAlD
Zonisamide—CA11—bone marrow—sarcoma	0.00293	0.0122	CbGeAlD
Zonisamide—SCN4B—testis—sarcoma	0.00291	0.0121	CbGeAlD
Zonisamide—CA5B—mammary gland—sarcoma	0.00291	0.0121	CbGeAlD
Zonisamide—CACNA1I—testis—sarcoma	0.00284	0.0118	CbGeAlD
Zonisamide—CA13—liver—sarcoma	0.00282	0.0117	CbGeAlD
Zonisamide—CACNA1H—myometrium—sarcoma	0.00271	0.0112	CbGeAlD
Zonisamide—SCN1B—lymph node—sarcoma	0.00269	0.0112	CbGeAlD
Zonisamide—CA3—connective tissue—sarcoma	0.00268	0.0111	CbGeAlD
Zonisamide—CA14—seminal vesicle—sarcoma	0.00266	0.0111	CbGeAlD
Zonisamide—CA8—lymph node—sarcoma	0.00253	0.0105	CbGeAlD
Zonisamide—CA11—testis—sarcoma	0.0025	0.0104	CbGeAlD
Zonisamide—SCN3B—lymph node—sarcoma	0.00248	0.0103	CbGeAlD
Zonisamide—CACNA1H—seminal vesicle—sarcoma	0.00245	0.0102	CbGeAlD
Zonisamide—CA5A—liver—sarcoma	0.00237	0.00983	CbGeAlD
Zonisamide—CA13—lymph node—sarcoma	0.00216	0.00898	CbGeAlD
Zonisamide—CA3—cardiac atrium—sarcoma	0.00212	0.00879	CbGeAlD
Zonisamide—SCN4B—lymph node—sarcoma	0.00211	0.00875	CbGeAlD
Zonisamide—CA3—uterus—sarcoma	0.00211	0.00874	CbGeAlD
Zonisamide—CACNA1I—lymph node—sarcoma	0.00206	0.00855	CbGeAlD
Zonisamide—CACNA1H—smooth muscle tissue—sarcoma	0.00205	0.0085	CbGeAlD
Zonisamide—SCN2A—hematopoietic system—sarcoma	0.00196	0.00813	CbGeAlD
Zonisamide—CA14—cardiac atrium—sarcoma	0.00192	0.00798	CbGeAlD
Zonisamide—AOX1—myometrium—sarcoma	0.00192	0.00797	CbGeAlD
Zonisamide—CA12—connective tissue—sarcoma	0.0019	0.00789	CbGeAlD
Zonisamide—CA3—tendon—sarcoma	0.00184	0.00766	CbGeAlD
Zonisamide—CA11—lymph node—sarcoma	0.00181	0.00754	CbGeAlD
Zonisamide—CA3—bone marrow—sarcoma	0.00179	0.00742	CbGeAlD
Zonisamide—CA5B—hematopoietic system—sarcoma	0.00177	0.00735	CbGeAlD
Zonisamide—CA9—tendon—sarcoma	0.00177	0.00733	CbGeAlD
Zonisamide—CACNA1H—uterus—sarcoma	0.00176	0.00729	CbGeAlD
Zonisamide—AOX1—seminal vesicle—sarcoma	0.00173	0.0072	CbGeAlD
Zonisamide—CA14—tendon—sarcoma	0.00168	0.00696	CbGeAlD
Zonisamide—SCN9A—tendon—sarcoma	0.00164	0.00682	CbGeAlD
Zonisamide—CA1—hematopoietic system—sarcoma	0.00156	0.00649	CbGeAlD
Zonisamide—CA3—testis—sarcoma	0.00153	0.00634	CbGeAlD
Zonisamide—MAOB—myometrium—sarcoma	0.00148	0.00614	CbGeAlD
Zonisamide—SCN4A—tendon—sarcoma	0.00146	0.00608	CbGeAlD
Zonisamide—CA9—testis—sarcoma	0.00146	0.00607	CbGeAlD
Zonisamide—CA3—liver—sarcoma	0.00144	0.006	CbGeAlD
Zonisamide—MAOB—embryo—sarcoma	0.00142	0.0059	CbGeAlD
Zonisamide—SCN9A—testis—sarcoma	0.00136	0.00564	CbGeAlD
Zonisamide—CA5B—cardiac atrium—sarcoma	0.00134	0.00558	CbGeAlD
Zonisamide—MAOB—seminal vesicle—sarcoma	0.00134	0.00554	CbGeAlD
Zonisamide—CA14—liver—sarcoma	0.00131	0.00545	CbGeAlD
Zonisamide—SCN5A—cardiac atrium—sarcoma	0.0013	0.00541	CbGeAlD
Zonisamide—CA4—seminal vesicle—sarcoma	0.00129	0.00534	CbGeAlD
Zonisamide—CACNA1H—testis—sarcoma	0.00127	0.00529	CbGeAlD
Zonisamide—MAOB—hematopoietic system—sarcoma	0.00127	0.00527	CbGeAlD
Zonisamide—MAOA—myometrium—sarcoma	0.00126	0.00524	CbGeAlD
Zonisamide—AOX1—cardiac atrium—sarcoma	0.00125	0.00519	CbGeAlD
Zonisamide—AOX1—uterus—sarcoma	0.00124	0.00517	CbGeAlD
Zonisamide—MAOB—connective tissue—sarcoma	0.00122	0.00507	CbGeAlD
Zonisamide—MAOA—embryo—sarcoma	0.00121	0.00504	CbGeAlD
Zonisamide—SCN4A—testis—sarcoma	0.00121	0.00504	CbGeAlD
Zonisamide—CACNA1H—liver—sarcoma	0.0012	0.005	CbGeAlD
Zonisamide—CA5B—tendon—sarcoma	0.00117	0.00487	CbGeAlD
Zonisamide—MAOA—seminal vesicle—sarcoma	0.00114	0.00473	CbGeAlD
Zonisamide—SCN3A—tendon—sarcoma	0.00114	0.00473	CbGeAlD
Zonisamide—CA2—embryo—sarcoma	0.00114	0.00471	CbGeAlD
Zonisamide—CA3—lymph node—sarcoma	0.00111	0.0046	CbGeAlD
Zonisamide—CYP2C19—hematopoietic system—sarcoma	0.00111	0.00459	CbGeAlD
Zonisamide—SCN3A—bone marrow—sarcoma	0.0011	0.00458	CbGeAlD
Zonisamide—CA1—lymphoid tissue—sarcoma	0.0011	0.00457	CbGeAlD
Zonisamide—AOX1—tendon—sarcoma	0.00109	0.00453	CbGeAlD
Zonisamide—MAOA—hematopoietic system—sarcoma	0.00108	0.0045	CbGeAlD
Zonisamide—CA2—seminal vesicle—sarcoma	0.00107	0.00443	CbGeAlD
Zonisamide—MAOA—connective tissue—sarcoma	0.00104	0.00433	CbGeAlD
Zonisamide—CA2—hematopoietic system—sarcoma	0.00101	0.00421	CbGeAlD
Zonisamide—CA1—bone marrow—sarcoma	0.001	0.00416	CbGeAlD
Zonisamide—SCN9A—lymph node—sarcoma	0.000985	0.00409	CbGeAlD
Zonisamide—CA2—connective tissue—sarcoma	0.000976	0.00405	CbGeAlD
Zonisamide—CA5B—testis—sarcoma	0.00097	0.00403	CbGeAlD
Zonisamide—MAOB—cardiac atrium—sarcoma	0.000964	0.004	CbGeAlD
Zonisamide—MAOB—uterus—sarcoma	0.000959	0.00398	CbGeAlD
Zonisamide—SCN3A—testis—sarcoma	0.000943	0.00392	CbGeAlD
Zonisamide—CA4—cardiac atrium—sarcoma	0.000928	0.00385	CbGeAlD
Zonisamide—CACNA1H—lymph node—sarcoma	0.000923	0.00383	CbGeAlD
Zonisamide—AOX1—testis—sarcoma	0.000902	0.00375	CbGeAlD
Zonisamide—CA2—smooth muscle tissue—sarcoma	0.000893	0.00371	CbGeAlD
Zonisamide—CA2—skin of body—sarcoma	0.000881	0.00366	CbGeAlD
Zonisamide—AOX1—liver—sarcoma	0.000853	0.00354	CbGeAlD
Zonisamide—MAOB—tendon—sarcoma	0.00084	0.00349	CbGeAlD
Zonisamide—MAOA—cardiac atrium—sarcoma	0.000822	0.00341	CbGeAlD
Zonisamide—MAOA—uterus—sarcoma	0.000818	0.0034	CbGeAlD
Zonisamide—CA1—liver—sarcoma	0.00081	0.00336	CbGeAlD
Zonisamide—CA4—tendon—sarcoma	0.000809	0.00336	CbGeAlD
Zonisamide—CA4—bone marrow—sarcoma	0.000784	0.00325	CbGeAlD
Zonisamide—CA2—cardiac atrium—sarcoma	0.00077	0.0032	CbGeAlD
Zonisamide—MAOA—tendon—sarcoma	0.000717	0.00298	CbGeAlD
Zonisamide—CA2—lymphoid tissue—sarcoma	0.000714	0.00296	CbGeAlD
Zonisamide—CA5B—lymph node—sarcoma	0.000703	0.00292	CbGeAlD
Zonisamide—MAOB—testis—sarcoma	0.000695	0.00289	CbGeAlD
Zonisamide—SCN3A—lymph node—sarcoma	0.000684	0.00284	CbGeAlD
Zonisamide—CA2—tendon—sarcoma	0.000671	0.00279	CbGeAlD
Zonisamide—CA4—testis—sarcoma	0.00067	0.00278	CbGeAlD
Zonisamide—MAOB—liver—sarcoma	0.000657	0.00273	CbGeAlD
Zonisamide—AOX1—lymph node—sarcoma	0.000654	0.00272	CbGeAlD
Zonisamide—CYP3A4—hematopoietic system—sarcoma	0.000654	0.00272	CbGeAlD
Zonisamide—CA2—bone marrow—sarcoma	0.00065	0.0027	CbGeAlD
Zonisamide—CA1—lymph node—sarcoma	0.000621	0.00258	CbGeAlD
Zonisamide—MAOA—testis—sarcoma	0.000593	0.00246	CbGeAlD
Zonisamide—CYP2C19—liver—sarcoma	0.000573	0.00238	CbGeAlD
Zonisamide—MAOA—liver—sarcoma	0.000561	0.00233	CbGeAlD
Zonisamide—CA2—testis—sarcoma	0.000555	0.00231	CbGeAlD
Zonisamide—CA2—liver—sarcoma	0.000525	0.00218	CbGeAlD
Zonisamide—MAOB—lymph node—sarcoma	0.000504	0.00209	CbGeAlD
Zonisamide—CA4—lymph node—sarcoma	0.000486	0.00202	CbGeAlD
Zonisamide—MAOA—lymph node—sarcoma	0.00043	0.00179	CbGeAlD
Zonisamide—Dry skin—Doxorubicin—sarcoma	0.00043	0.000985	CcSEcCtD
Zonisamide—Hyperhidrosis—Etoposide—sarcoma	0.000429	0.000984	CcSEcCtD
Zonisamide—Pancreatitis—Epirubicin—sarcoma	0.000429	0.000984	CcSEcCtD
Zonisamide—Hypokalaemia—Doxorubicin—sarcoma	0.000426	0.000978	CcSEcCtD
Zonisamide—Urticaria—Mitoxantrone—sarcoma	0.000424	0.000972	CcSEcCtD
Zonisamide—Anorexia—Etoposide—sarcoma	0.000423	0.00097	CcSEcCtD
Zonisamide—Diarrhoea—Thiotepa—sarcoma	0.000423	0.00097	CcSEcCtD
Zonisamide—Abdominal pain—Mitoxantrone—sarcoma	0.000422	0.000968	CcSEcCtD
Zonisamide—Body temperature increased—Mitoxantrone—sarcoma	0.000422	0.000968	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000422	0.000967	CcSEcCtD
Zonisamide—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000422	0.000967	CcSEcCtD
Zonisamide—Diarrhoea—Dactinomycin—sarcoma	0.00042	0.000962	CcSEcCtD
Zonisamide—Pancytopenia—Epirubicin—sarcoma	0.000416	0.000953	CcSEcCtD
Zonisamide—Hypotension—Etoposide—sarcoma	0.000415	0.000951	CcSEcCtD
Zonisamide—Gastritis—Doxorubicin—sarcoma	0.000415	0.000951	CcSEcCtD
Zonisamide—Muscular weakness—Doxorubicin—sarcoma	0.000413	0.000948	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000413	0.000948	CcSEcCtD
Zonisamide—Dysuria—Epirubicin—sarcoma	0.000409	0.000938	CcSEcCtD
Zonisamide—Dizziness—Thiotepa—sarcoma	0.000409	0.000937	CcSEcCtD
Zonisamide—Dysphagia—Doxorubicin—sarcoma	0.000405	0.000929	CcSEcCtD
Zonisamide—Influenza—Doxorubicin—sarcoma	0.000405	0.000929	CcSEcCtD
Zonisamide—Pollakiuria—Epirubicin—sarcoma	0.000404	0.000927	CcSEcCtD
Zonisamide—Hypersensitivity—Vincristine—sarcoma	0.000404	0.000926	CcSEcCtD
Zonisamide—CA2—lymph node—sarcoma	0.000403	0.00167	CbGeAlD
Zonisamide—Eosinophilia—Doxorubicin—sarcoma	0.000401	0.000919	CcSEcCtD
Zonisamide—Paraesthesia—Etoposide—sarcoma	0.000399	0.000914	CcSEcCtD
Zonisamide—Weight increased—Epirubicin—sarcoma	0.000398	0.000913	CcSEcCtD
Zonisamide—Pancreatitis—Doxorubicin—sarcoma	0.000397	0.00091	CcSEcCtD
Zonisamide—Weight decreased—Epirubicin—sarcoma	0.000396	0.000908	CcSEcCtD
Zonisamide—Dyspnoea—Etoposide—sarcoma	0.000396	0.000908	CcSEcCtD
Zonisamide—Somnolence—Etoposide—sarcoma	0.000395	0.000905	CcSEcCtD
Zonisamide—Hypersensitivity—Mitoxantrone—sarcoma	0.000393	0.000902	CcSEcCtD
Zonisamide—Asthenia—Vincristine—sarcoma	0.000393	0.000902	CcSEcCtD
Zonisamide—Vomiting—Thiotepa—sarcoma	0.000393	0.000901	CcSEcCtD
Zonisamide—Pneumonia—Epirubicin—sarcoma	0.000393	0.0009	CcSEcCtD
Zonisamide—Vomiting—Dactinomycin—sarcoma	0.00039	0.000894	CcSEcCtD
Zonisamide—Rash—Thiotepa—sarcoma	0.00039	0.000894	CcSEcCtD
Zonisamide—Dermatitis—Thiotepa—sarcoma	0.000389	0.000893	CcSEcCtD
Zonisamide—Headache—Thiotepa—sarcoma	0.000387	0.000888	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000387	0.000887	CcSEcCtD
Zonisamide—Rash—Dactinomycin—sarcoma	0.000387	0.000887	CcSEcCtD
Zonisamide—Decreased appetite—Etoposide—sarcoma	0.000386	0.000885	CcSEcCtD
Zonisamide—Pancytopenia—Doxorubicin—sarcoma	0.000385	0.000882	CcSEcCtD
Zonisamide—Renal failure—Epirubicin—sarcoma	0.000384	0.00088	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Etoposide—sarcoma	0.000383	0.000879	CcSEcCtD
Zonisamide—Asthenia—Mitoxantrone—sarcoma	0.000383	0.000878	CcSEcCtD
Zonisamide—Fatigue—Etoposide—sarcoma	0.000383	0.000878	CcSEcCtD
Zonisamide—Neuropathy peripheral—Epirubicin—sarcoma	0.000383	0.000877	CcSEcCtD
Zonisamide—Stomatitis—Epirubicin—sarcoma	0.00038	0.000872	CcSEcCtD
Zonisamide—Constipation—Etoposide—sarcoma	0.00038	0.000871	CcSEcCtD
Zonisamide—Urinary tract infection—Epirubicin—sarcoma	0.000379	0.00087	CcSEcCtD
Zonisamide—Conjunctivitis—Epirubicin—sarcoma	0.000379	0.00087	CcSEcCtD
Zonisamide—Dysuria—Doxorubicin—sarcoma	0.000379	0.000868	CcSEcCtD
Zonisamide—Diarrhoea—Vincristine—sarcoma	0.000375	0.00086	CcSEcCtD
Zonisamide—Sweating—Epirubicin—sarcoma	0.000374	0.000858	CcSEcCtD
Zonisamide—Pollakiuria—Doxorubicin—sarcoma	0.000374	0.000858	CcSEcCtD
Zonisamide—Haematuria—Epirubicin—sarcoma	0.000372	0.000853	CcSEcCtD
Zonisamide—Hepatobiliary disease—Epirubicin—sarcoma	0.000369	0.000846	CcSEcCtD
Zonisamide—Weight increased—Doxorubicin—sarcoma	0.000369	0.000845	CcSEcCtD
Zonisamide—Nausea—Thiotepa—sarcoma	0.000367	0.000842	CcSEcCtD
Zonisamide—Weight decreased—Doxorubicin—sarcoma	0.000366	0.00084	CcSEcCtD
Zonisamide—Feeling abnormal—Etoposide—sarcoma	0.000366	0.000839	CcSEcCtD
Zonisamide—Diarrhoea—Mitoxantrone—sarcoma	0.000365	0.000837	CcSEcCtD
Zonisamide—Nausea—Dactinomycin—sarcoma	0.000364	0.000836	CcSEcCtD
Zonisamide—Agranulocytosis—Epirubicin—sarcoma	0.000364	0.000835	CcSEcCtD
Zonisamide—Pneumonia—Doxorubicin—sarcoma	0.000363	0.000833	CcSEcCtD
Zonisamide—Gastrointestinal pain—Etoposide—sarcoma	0.000363	0.000833	CcSEcCtD
Zonisamide—Dizziness—Vincristine—sarcoma	0.000363	0.000831	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000358	0.000821	CcSEcCtD
Zonisamide—Bradycardia—Epirubicin—sarcoma	0.000357	0.000818	CcSEcCtD
Zonisamide—Renal failure—Doxorubicin—sarcoma	0.000355	0.000814	CcSEcCtD
Zonisamide—Neuropathy peripheral—Doxorubicin—sarcoma	0.000354	0.000812	CcSEcCtD
Zonisamide—Urticaria—Etoposide—sarcoma	0.000353	0.000809	CcSEcCtD
Zonisamide—Stomatitis—Doxorubicin—sarcoma	0.000352	0.000807	CcSEcCtD
Zonisamide—Rhinitis—Epirubicin—sarcoma	0.000351	0.000805	CcSEcCtD
Zonisamide—Abdominal pain—Etoposide—sarcoma	0.000351	0.000805	CcSEcCtD
Zonisamide—Body temperature increased—Etoposide—sarcoma	0.000351	0.000805	CcSEcCtD
Zonisamide—Urinary tract infection—Doxorubicin—sarcoma	0.000351	0.000805	CcSEcCtD
Zonisamide—Conjunctivitis—Doxorubicin—sarcoma	0.000351	0.000805	CcSEcCtD
Zonisamide—Vomiting—Vincristine—sarcoma	0.000349	0.000799	CcSEcCtD
Zonisamide—Pharyngitis—Epirubicin—sarcoma	0.000348	0.000797	CcSEcCtD
Zonisamide—Sweating—Doxorubicin—sarcoma	0.000346	0.000794	CcSEcCtD
Zonisamide—Urinary tract disorder—Epirubicin—sarcoma	0.000346	0.000793	CcSEcCtD
Zonisamide—Rash—Vincristine—sarcoma	0.000346	0.000792	CcSEcCtD
Zonisamide—Dermatitis—Vincristine—sarcoma	0.000345	0.000792	CcSEcCtD
Zonisamide—Oedema peripheral—Epirubicin—sarcoma	0.000345	0.000791	CcSEcCtD
Zonisamide—Haematuria—Doxorubicin—sarcoma	0.000344	0.000789	CcSEcCtD
Zonisamide—Connective tissue disorder—Epirubicin—sarcoma	0.000344	0.000789	CcSEcCtD
Zonisamide—Urethral disorder—Epirubicin—sarcoma	0.000343	0.000787	CcSEcCtD
Zonisamide—Headache—Vincristine—sarcoma	0.000343	0.000787	CcSEcCtD
Zonisamide—Hepatobiliary disease—Doxorubicin—sarcoma	0.000342	0.000783	CcSEcCtD
Zonisamide—Vomiting—Mitoxantrone—sarcoma	0.000339	0.000778	CcSEcCtD
Zonisamide—CYP3A4—liver—sarcoma	0.000339	0.00141	CbGeAlD
Zonisamide—Agranulocytosis—Doxorubicin—sarcoma	0.000337	0.000773	CcSEcCtD
Zonisamide—Rash—Mitoxantrone—sarcoma	0.000337	0.000772	CcSEcCtD
Zonisamide—Dermatitis—Mitoxantrone—sarcoma	0.000336	0.000771	CcSEcCtD
Zonisamide—Headache—Mitoxantrone—sarcoma	0.000334	0.000767	CcSEcCtD
Zonisamide—Erythema multiforme—Epirubicin—sarcoma	0.000331	0.00076	CcSEcCtD
Zonisamide—Bradycardia—Doxorubicin—sarcoma	0.00033	0.000757	CcSEcCtD
Zonisamide—Eye disorder—Epirubicin—sarcoma	0.000327	0.000751	CcSEcCtD
Zonisamide—Hypersensitivity—Etoposide—sarcoma	0.000327	0.00075	CcSEcCtD
Zonisamide—Tinnitus—Epirubicin—sarcoma	0.000327	0.000749	CcSEcCtD
Zonisamide—Nausea—Vincristine—sarcoma	0.000326	0.000747	CcSEcCtD
Zonisamide—Rhinitis—Doxorubicin—sarcoma	0.000325	0.000745	CcSEcCtD
Zonisamide—Pharyngitis—Doxorubicin—sarcoma	0.000322	0.000738	CcSEcCtD
Zonisamide—Urinary tract disorder—Doxorubicin—sarcoma	0.00032	0.000734	CcSEcCtD
Zonisamide—Oedema peripheral—Doxorubicin—sarcoma	0.000319	0.000732	CcSEcCtD
Zonisamide—Asthenia—Etoposide—sarcoma	0.000319	0.00073	CcSEcCtD
Zonisamide—Connective tissue disorder—Doxorubicin—sarcoma	0.000319	0.00073	CcSEcCtD
Zonisamide—Urethral disorder—Doxorubicin—sarcoma	0.000318	0.000729	CcSEcCtD
Zonisamide—Nausea—Mitoxantrone—sarcoma	0.000317	0.000727	CcSEcCtD
Zonisamide—Immune system disorder—Epirubicin—sarcoma	0.000316	0.000726	CcSEcCtD
Zonisamide—Mediastinal disorder—Epirubicin—sarcoma	0.000316	0.000724	CcSEcCtD
Zonisamide—Pruritus—Etoposide—sarcoma	0.000314	0.00072	CcSEcCtD
Zonisamide—Alopecia—Epirubicin—sarcoma	0.00031	0.00071	CcSEcCtD
Zonisamide—Mental disorder—Epirubicin—sarcoma	0.000307	0.000704	CcSEcCtD
Zonisamide—Erythema multiforme—Doxorubicin—sarcoma	0.000307	0.000703	CcSEcCtD
Zonisamide—Malnutrition—Epirubicin—sarcoma	0.000305	0.000699	CcSEcCtD
Zonisamide—Diarrhoea—Etoposide—sarcoma	0.000304	0.000697	CcSEcCtD
Zonisamide—Eye disorder—Doxorubicin—sarcoma	0.000303	0.000695	CcSEcCtD
Zonisamide—Tinnitus—Doxorubicin—sarcoma	0.000302	0.000693	CcSEcCtD
Zonisamide—Flatulence—Epirubicin—sarcoma	0.000301	0.000689	CcSEcCtD
Zonisamide—Tension—Epirubicin—sarcoma	0.000299	0.000686	CcSEcCtD
Zonisamide—Dysgeusia—Epirubicin—sarcoma	0.000299	0.000685	CcSEcCtD
Zonisamide—Nervousness—Epirubicin—sarcoma	0.000296	0.000679	CcSEcCtD
Zonisamide—Dizziness—Etoposide—sarcoma	0.000294	0.000673	CcSEcCtD
Zonisamide—Muscle spasms—Epirubicin—sarcoma	0.000293	0.000672	CcSEcCtD
Zonisamide—Immune system disorder—Doxorubicin—sarcoma	0.000293	0.000671	CcSEcCtD
Zonisamide—Mediastinal disorder—Doxorubicin—sarcoma	0.000292	0.00067	CcSEcCtD
Zonisamide—Alopecia—Doxorubicin—sarcoma	0.000286	0.000657	CcSEcCtD
Zonisamide—Mental disorder—Doxorubicin—sarcoma	0.000284	0.000651	CcSEcCtD
Zonisamide—Ill-defined disorder—Epirubicin—sarcoma	0.000283	0.000649	CcSEcCtD
Zonisamide—Vomiting—Etoposide—sarcoma	0.000282	0.000647	CcSEcCtD
Zonisamide—Malnutrition—Doxorubicin—sarcoma	0.000282	0.000647	CcSEcCtD
Zonisamide—Anaemia—Epirubicin—sarcoma	0.000282	0.000646	CcSEcCtD
Zonisamide—Agitation—Epirubicin—sarcoma	0.00028	0.000643	CcSEcCtD
Zonisamide—Rash—Etoposide—sarcoma	0.00028	0.000642	CcSEcCtD
Zonisamide—Dermatitis—Etoposide—sarcoma	0.00028	0.000641	CcSEcCtD
Zonisamide—Headache—Etoposide—sarcoma	0.000278	0.000638	CcSEcCtD
Zonisamide—Flatulence—Doxorubicin—sarcoma	0.000278	0.000638	CcSEcCtD
Zonisamide—Tension—Doxorubicin—sarcoma	0.000277	0.000635	CcSEcCtD
Zonisamide—Dysgeusia—Doxorubicin—sarcoma	0.000276	0.000634	CcSEcCtD
Zonisamide—Malaise—Epirubicin—sarcoma	0.000275	0.000631	CcSEcCtD
Zonisamide—Nervousness—Doxorubicin—sarcoma	0.000274	0.000628	CcSEcCtD
Zonisamide—Vertigo—Epirubicin—sarcoma	0.000274	0.000628	CcSEcCtD
Zonisamide—Syncope—Epirubicin—sarcoma	0.000274	0.000627	CcSEcCtD
Zonisamide—Leukopenia—Epirubicin—sarcoma	0.000273	0.000626	CcSEcCtD
Zonisamide—Muscle spasms—Doxorubicin—sarcoma	0.000271	0.000622	CcSEcCtD
Zonisamide—Palpitations—Epirubicin—sarcoma	0.00027	0.000618	CcSEcCtD
Zonisamide—Loss of consciousness—Epirubicin—sarcoma	0.000268	0.000615	CcSEcCtD
Zonisamide—Cough—Epirubicin—sarcoma	0.000266	0.00061	CcSEcCtD
Zonisamide—Convulsion—Epirubicin—sarcoma	0.000264	0.000606	CcSEcCtD
Zonisamide—Nausea—Etoposide—sarcoma	0.000264	0.000605	CcSEcCtD
Zonisamide—Hypertension—Epirubicin—sarcoma	0.000263	0.000604	CcSEcCtD
Zonisamide—Ill-defined disorder—Doxorubicin—sarcoma	0.000262	0.0006	CcSEcCtD
Zonisamide—Anaemia—Doxorubicin—sarcoma	0.000261	0.000598	CcSEcCtD
Zonisamide—Arthralgia—Epirubicin—sarcoma	0.00026	0.000595	CcSEcCtD
Zonisamide—Chest pain—Epirubicin—sarcoma	0.00026	0.000595	CcSEcCtD
Zonisamide—Myalgia—Epirubicin—sarcoma	0.00026	0.000595	CcSEcCtD
Zonisamide—Agitation—Doxorubicin—sarcoma	0.000259	0.000595	CcSEcCtD
Zonisamide—Anxiety—Epirubicin—sarcoma	0.000259	0.000593	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000258	0.000591	CcSEcCtD
Zonisamide—Discomfort—Epirubicin—sarcoma	0.000257	0.000588	CcSEcCtD
Zonisamide—Malaise—Doxorubicin—sarcoma	0.000254	0.000583	CcSEcCtD
Zonisamide—Dry mouth—Epirubicin—sarcoma	0.000254	0.000582	CcSEcCtD
Zonisamide—Vertigo—Doxorubicin—sarcoma	0.000254	0.000581	CcSEcCtD
Zonisamide—Syncope—Doxorubicin—sarcoma	0.000253	0.00058	CcSEcCtD
Zonisamide—Leukopenia—Doxorubicin—sarcoma	0.000253	0.000579	CcSEcCtD
Zonisamide—Confusional state—Epirubicin—sarcoma	0.000251	0.000575	CcSEcCtD
Zonisamide—Palpitations—Doxorubicin—sarcoma	0.000249	0.000572	CcSEcCtD
Zonisamide—Oedema—Epirubicin—sarcoma	0.000249	0.000571	CcSEcCtD
Zonisamide—Loss of consciousness—Doxorubicin—sarcoma	0.000248	0.000569	CcSEcCtD
Zonisamide—Infection—Epirubicin—sarcoma	0.000247	0.000567	CcSEcCtD
Zonisamide—Cough—Doxorubicin—sarcoma	0.000246	0.000565	CcSEcCtD
Zonisamide—Shock—Epirubicin—sarcoma	0.000245	0.000561	CcSEcCtD
Zonisamide—Convulsion—Doxorubicin—sarcoma	0.000245	0.000561	CcSEcCtD
Zonisamide—Nervous system disorder—Epirubicin—sarcoma	0.000244	0.00056	CcSEcCtD
Zonisamide—Thrombocytopenia—Epirubicin—sarcoma	0.000244	0.000559	CcSEcCtD
Zonisamide—Hypertension—Doxorubicin—sarcoma	0.000244	0.000559	CcSEcCtD
Zonisamide—Tachycardia—Epirubicin—sarcoma	0.000243	0.000557	CcSEcCtD
Zonisamide—Skin disorder—Epirubicin—sarcoma	0.000242	0.000554	CcSEcCtD
Zonisamide—Hyperhidrosis—Epirubicin—sarcoma	0.000241	0.000552	CcSEcCtD
Zonisamide—Myalgia—Doxorubicin—sarcoma	0.00024	0.000551	CcSEcCtD
Zonisamide—Arthralgia—Doxorubicin—sarcoma	0.00024	0.000551	CcSEcCtD
Zonisamide—Chest pain—Doxorubicin—sarcoma	0.00024	0.000551	CcSEcCtD
Zonisamide—Anxiety—Doxorubicin—sarcoma	0.000239	0.000549	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000239	0.000547	CcSEcCtD
Zonisamide—Discomfort—Doxorubicin—sarcoma	0.000237	0.000544	CcSEcCtD
Zonisamide—Anorexia—Epirubicin—sarcoma	0.000237	0.000544	CcSEcCtD
Zonisamide—Dry mouth—Doxorubicin—sarcoma	0.000235	0.000539	CcSEcCtD
Zonisamide—Hypotension—Epirubicin—sarcoma	0.000233	0.000533	CcSEcCtD
Zonisamide—Confusional state—Doxorubicin—sarcoma	0.000232	0.000532	CcSEcCtD
Zonisamide—Oedema—Doxorubicin—sarcoma	0.00023	0.000528	CcSEcCtD
Zonisamide—Infection—Doxorubicin—sarcoma	0.000229	0.000525	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000227	0.00052	CcSEcCtD
Zonisamide—Shock—Doxorubicin—sarcoma	0.000227	0.00052	CcSEcCtD
Zonisamide—Nervous system disorder—Doxorubicin—sarcoma	0.000226	0.000518	CcSEcCtD
Zonisamide—Thrombocytopenia—Doxorubicin—sarcoma	0.000226	0.000517	CcSEcCtD
Zonisamide—Insomnia—Epirubicin—sarcoma	0.000225	0.000516	CcSEcCtD
Zonisamide—Tachycardia—Doxorubicin—sarcoma	0.000225	0.000515	CcSEcCtD
Zonisamide—Skin disorder—Doxorubicin—sarcoma	0.000224	0.000513	CcSEcCtD
Zonisamide—Paraesthesia—Epirubicin—sarcoma	0.000224	0.000512	CcSEcCtD
Zonisamide—Hyperhidrosis—Doxorubicin—sarcoma	0.000223	0.00051	CcSEcCtD
Zonisamide—Dyspnoea—Epirubicin—sarcoma	0.000222	0.000509	CcSEcCtD
Zonisamide—Somnolence—Epirubicin—sarcoma	0.000221	0.000507	CcSEcCtD
Zonisamide—Anorexia—Doxorubicin—sarcoma	0.00022	0.000503	CcSEcCtD
Zonisamide—Dyspepsia—Epirubicin—sarcoma	0.000219	0.000502	CcSEcCtD
Zonisamide—Decreased appetite—Epirubicin—sarcoma	0.000216	0.000496	CcSEcCtD
Zonisamide—Hypotension—Doxorubicin—sarcoma	0.000215	0.000493	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000215	0.000493	CcSEcCtD
Zonisamide—Fatigue—Epirubicin—sarcoma	0.000215	0.000492	CcSEcCtD
Zonisamide—Constipation—Epirubicin—sarcoma	0.000213	0.000488	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00021	0.000481	CcSEcCtD
Zonisamide—Insomnia—Doxorubicin—sarcoma	0.000208	0.000478	CcSEcCtD
Zonisamide—Paraesthesia—Doxorubicin—sarcoma	0.000207	0.000474	CcSEcCtD
Zonisamide—Dyspnoea—Doxorubicin—sarcoma	0.000205	0.000471	CcSEcCtD
Zonisamide—Feeling abnormal—Epirubicin—sarcoma	0.000205	0.00047	CcSEcCtD
Zonisamide—Somnolence—Doxorubicin—sarcoma	0.000205	0.000469	CcSEcCtD
Zonisamide—SCN2A—Developmental Biology—FOXO1—sarcoma	0.000204	0.000631	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—FOXO1—sarcoma	0.000204	0.000631	CbGpPWpGaD
Zonisamide—Gastrointestinal pain—Epirubicin—sarcoma	0.000204	0.000467	CcSEcCtD
Zonisamide—CA14—Metabolism—ENO2—sarcoma	0.000203	0.000629	CbGpPWpGaD
Zonisamide—Dyspepsia—Doxorubicin—sarcoma	0.000203	0.000465	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—MMP2—sarcoma	0.000202	0.000627	CbGpPWpGaD
Zonisamide—CA14—Metabolism—HBA1—sarcoma	0.000202	0.000625	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—VEGFA—sarcoma	0.000202	0.000625	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—MMP2—sarcoma	0.000201	0.000621	CbGpPWpGaD
Zonisamide—Decreased appetite—Doxorubicin—sarcoma	0.0002	0.000459	CcSEcCtD
Zonisamide—SCN1A—Axon guidance—CREB1—sarcoma	0.0002	0.000618	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—NRAS—sarcoma	0.000199	0.000617	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—PTPRC—sarcoma	0.000199	0.000616	CbGpPWpGaD
Zonisamide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000199	0.000456	CcSEcCtD
Zonisamide—Fatigue—Doxorubicin—sarcoma	0.000199	0.000455	CcSEcCtD
Zonisamide—CA5A—Metabolism—ENO2—sarcoma	0.000198	0.000613	CbGpPWpGaD
Zonisamide—CA6—Metabolism—ENO2—sarcoma	0.000198	0.000613	CbGpPWpGaD
Zonisamide—Urticaria—Epirubicin—sarcoma	0.000198	0.000453	CcSEcCtD
Zonisamide—Constipation—Doxorubicin—sarcoma	0.000197	0.000452	CcSEcCtD
Zonisamide—CA6—Metabolism—HBA1—sarcoma	0.000197	0.000609	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—HBA1—sarcoma	0.000197	0.000609	CbGpPWpGaD
Zonisamide—Body temperature increased—Epirubicin—sarcoma	0.000197	0.000451	CcSEcCtD
Zonisamide—Abdominal pain—Epirubicin—sarcoma	0.000197	0.000451	CcSEcCtD
Zonisamide—SCN11A—Axon guidance—SRC—sarcoma	0.000197	0.000608	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—FOXO1—sarcoma	0.000196	0.000608	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—PLCG1—sarcoma	0.000195	0.000603	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—KDR—sarcoma	0.000193	0.000597	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—HRAS—sarcoma	0.000193	0.000597	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—MMP2—sarcoma	0.000193	0.000597	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—MMP2—sarcoma	0.000193	0.000597	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—VEGFA—sarcoma	0.000191	0.000593	CbGpPWpGaD
Zonisamide—Feeling abnormal—Doxorubicin—sarcoma	0.00019	0.000435	CcSEcCtD
Zonisamide—SCN11A—Axon guidance—NRAS—sarcoma	0.000189	0.000585	CbGpPWpGaD
Zonisamide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000188	0.000432	CcSEcCtD
Zonisamide—AOX1—Disease—TLE1—sarcoma	0.000188	0.000582	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—KDR—sarcoma	0.000187	0.000578	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—MMP2—sarcoma	0.000186	0.000576	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—ENO2—sarcoma	0.000185	0.000572	CbGpPWpGaD
Zonisamide—CA7—Metabolism—ENO2—sarcoma	0.000185	0.000572	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—HBA1—sarcoma	0.000184	0.000569	CbGpPWpGaD
Zonisamide—CA7—Metabolism—HBA1—sarcoma	0.000184	0.000569	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—KDR—sarcoma	0.000183	0.000568	CbGpPWpGaD
Zonisamide—Hypersensitivity—Epirubicin—sarcoma	0.000183	0.00042	CcSEcCtD
Zonisamide—Urticaria—Doxorubicin—sarcoma	0.000183	0.00042	CcSEcCtD
Zonisamide—Body temperature increased—Doxorubicin—sarcoma	0.000182	0.000417	CcSEcCtD
Zonisamide—Abdominal pain—Doxorubicin—sarcoma	0.000182	0.000417	CcSEcCtD
Zonisamide—CACNA1I—Axon guidance—EGFR—sarcoma	0.000182	0.000563	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—JUN—sarcoma	0.000181	0.000561	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—CREB1—sarcoma	0.00018	0.000558	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.00018	0.000557	CbGpPWpGaD
Zonisamide—Asthenia—Epirubicin—sarcoma	0.000179	0.000409	CcSEcCtD
Zonisamide—Pruritus—Epirubicin—sarcoma	0.000176	0.000404	CcSEcCtD
Zonisamide—SCN3A—Developmental Biology—KDR—sarcoma	0.000175	0.000543	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PLCG1—sarcoma	0.000172	0.000534	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—EGFR—sarcoma	0.000172	0.000533	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—KRAS—sarcoma	0.000172	0.000531	CbGpPWpGaD
Zonisamide—CA12—Metabolism—ENO2—sarcoma	0.000171	0.00053	CbGpPWpGaD
Zonisamide—Diarrhoea—Epirubicin—sarcoma	0.00017	0.00039	CcSEcCtD
Zonisamide—CA12—Metabolism—HBA1—sarcoma	0.00017	0.000527	CbGpPWpGaD
Zonisamide—AOX1—Disease—NPM1—sarcoma	0.00017	0.000525	CbGpPWpGaD
Zonisamide—Hypersensitivity—Doxorubicin—sarcoma	0.00017	0.000389	CcSEcCtD
Zonisamide—CACNA1G—Developmental Biology—CREB1—sarcoma	0.000169	0.000523	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—KDR—sarcoma	0.000169	0.000522	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—KDR—sarcoma	0.000169	0.000522	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PLCG1—sarcoma	0.000168	0.00052	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PLCG1—sarcoma	0.000168	0.00052	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—MDM2—sarcoma	0.000166	0.000512	CbGpPWpGaD
Zonisamide—Asthenia—Doxorubicin—sarcoma	0.000165	0.000379	CcSEcCtD
Zonisamide—Dizziness—Epirubicin—sarcoma	0.000165	0.000377	CcSEcCtD
Zonisamide—CACNA1H—Developmental Biology—CREB1—sarcoma	0.000164	0.000507	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—CTNNB1—sarcoma	0.000164	0.000507	CbGpPWpGaD
Zonisamide—Pruritus—Doxorubicin—sarcoma	0.000163	0.000374	CcSEcCtD
Zonisamide—SCN11A—Axon guidance—KRAS—sarcoma	0.000163	0.000504	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—KDR—sarcoma	0.000163	0.000503	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—CREB1—sarcoma	0.000161	0.000498	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—KDR—sarcoma	0.00016	0.000496	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000158	0.00049	CbGpPWpGaD
Zonisamide—Vomiting—Epirubicin—sarcoma	0.000158	0.000363	CcSEcCtD
Zonisamide—Diarrhoea—Doxorubicin—sarcoma	0.000158	0.000361	CcSEcCtD
Zonisamide—CACNA1G—Developmental Biology—MMP2—sarcoma	0.000157	0.000487	CbGpPWpGaD
Zonisamide—Rash—Epirubicin—sarcoma	0.000157	0.00036	CcSEcCtD
Zonisamide—CA7—Metabolism—PLCG1—sarcoma	0.000157	0.000486	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PLCG1—sarcoma	0.000157	0.000486	CbGpPWpGaD
Zonisamide—Dermatitis—Epirubicin—sarcoma	0.000157	0.00036	CcSEcCtD
Zonisamide—Headache—Epirubicin—sarcoma	0.000156	0.000358	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—CTNNB1—sarcoma	0.000155	0.00048	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—CREB1—sarcoma	0.000154	0.000476	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—SRC—sarcoma	0.000153	0.000473	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MMP2—sarcoma	0.000152	0.000472	CbGpPWpGaD
Zonisamide—Dizziness—Doxorubicin—sarcoma	0.000152	0.000349	CcSEcCtD
Zonisamide—SCN9A—Developmental Biology—MMP2—sarcoma	0.00015	0.000463	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—VEGFA—sarcoma	0.000149	0.000461	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—SRC—sarcoma	0.000148	0.000458	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—SRC—sarcoma	0.000148	0.000458	CbGpPWpGaD
Zonisamide—Nausea—Epirubicin—sarcoma	0.000148	0.000339	CcSEcCtD
Zonisamide—SCN2A—Developmental Biology—CREB1—sarcoma	0.000148	0.000458	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—CREB1—sarcoma	0.000148	0.000458	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—CREB1—sarcoma	0.000148	0.000457	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—NRAS—sarcoma	0.000147	0.000455	CbGpPWpGaD
Zonisamide—AOX1—Disease—ENO2—sarcoma	0.000147	0.000455	CbGpPWpGaD
Zonisamide—Vomiting—Doxorubicin—sarcoma	0.000146	0.000336	CcSEcCtD
Zonisamide—CACNA1I—Axon guidance—HRAS—sarcoma	0.000146	0.000452	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—SRC—sarcoma	0.000145	0.00045	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PLCG1—sarcoma	0.000145	0.00045	CbGpPWpGaD
Zonisamide—Rash—Doxorubicin—sarcoma	0.000145	0.000333	CcSEcCtD
Zonisamide—Dermatitis—Doxorubicin—sarcoma	0.000145	0.000333	CcSEcCtD
Zonisamide—Headache—Doxorubicin—sarcoma	0.000144	0.000331	CcSEcCtD
Zonisamide—CACNA1H—Axon guidance—VEGFA—sarcoma	0.000144	0.000446	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—VEGFA—sarcoma	0.000144	0.000446	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—JUN—sarcoma	0.000144	0.000445	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MMP2—sarcoma	0.000143	0.000443	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—CREB1—sarcoma	0.000143	0.000441	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—NRAS—sarcoma	0.000142	0.000441	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—NRAS—sarcoma	0.000142	0.000441	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—VEGFA—sarcoma	0.000142	0.000438	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—CREB1—sarcoma	0.00014	0.000435	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—SRC—sarcoma	0.00014	0.000434	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—NRAS—sarcoma	0.00014	0.000433	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—SRC—sarcoma	0.000139	0.00043	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—HRAS—sarcoma	0.000138	0.000428	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—FOXO1—sarcoma	0.000138	0.000428	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MMP2—sarcoma	0.000138	0.000426	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MMP2—sarcoma	0.000138	0.000426	CbGpPWpGaD
Zonisamide—Nausea—Doxorubicin—sarcoma	0.000137	0.000314	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—VEGFA—sarcoma	0.000137	0.000423	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ENO2—sarcoma	0.000137	0.000423	CbGpPWpGaD
Zonisamide—CA4—Metabolism—HBA1—sarcoma	0.000136	0.00042	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—VEGFA—sarcoma	0.000135	0.000419	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—NRAS—sarcoma	0.000135	0.000418	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—EGFR—sarcoma	0.000134	0.000415	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—NRAS—sarcoma	0.000134	0.000414	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—SRC—sarcoma	0.000134	0.000414	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—SRC—sarcoma	0.000134	0.000414	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MMP2—sarcoma	0.000133	0.000411	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ENO2—sarcoma	0.000131	0.000405	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MMP2—sarcoma	0.000131	0.000405	CbGpPWpGaD
Zonisamide—CA2—Metabolism—HBA1—sarcoma	0.00013	0.000403	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—VEGFA—sarcoma	0.00013	0.000403	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—VEGFA—sarcoma	0.00013	0.000403	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—EGFR—sarcoma	0.00013	0.000402	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—EGFR—sarcoma	0.00013	0.000401	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—JUN—sarcoma	0.00013	0.000401	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—SRC—sarcoma	0.000129	0.000399	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000129	0.000398	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—NRAS—sarcoma	0.000129	0.000398	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—NRAS—sarcoma	0.000129	0.000398	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—EGFR—sarcoma	0.000127	0.000394	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—KRAS—sarcoma	0.000127	0.000392	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—VEGFA—sarcoma	0.000126	0.000389	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ENO2—sarcoma	0.000126	0.000389	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—VEGFA—sarcoma	0.000125	0.000388	CbGpPWpGaD
Zonisamide—CA1—Metabolism—HBA1—sarcoma	0.000125	0.000386	CbGpPWpGaD
Zonisamide—AOX1—Disease—PLCG1—sarcoma	0.000125	0.000386	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—NRAS—sarcoma	0.000124	0.000384	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ENO2—sarcoma	0.000123	0.000381	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—EGFR—sarcoma	0.000123	0.000381	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—KRAS—sarcoma	0.000123	0.000379	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—KRAS—sarcoma	0.000123	0.000379	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—HBA1—sarcoma	0.000122	0.000379	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—MDM2—sarcoma	0.000122	0.000378	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—EGFR—sarcoma	0.000122	0.000377	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—CTNNB1—sarcoma	0.000121	0.000374	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—KRAS—sarcoma	0.00012	0.000373	CbGpPWpGaD
Zonisamide—AOX1—Disease—CXCR4—sarcoma	0.00012	0.000371	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—EGFR—sarcoma	0.000117	0.000363	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—EGFR—sarcoma	0.000117	0.000363	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—CTNNB1—sarcoma	0.000117	0.000362	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—KRAS—sarcoma	0.000116	0.00036	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PLCG1—sarcoma	0.000116	0.000359	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—KRAS—sarcoma	0.000115	0.000356	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—CTNNB1—sarcoma	0.000115	0.000355	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—KDR—sarcoma	0.000114	0.000354	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000113	0.000351	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—CREB1—sarcoma	0.000113	0.00035	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—EGFR—sarcoma	0.000113	0.00035	CbGpPWpGaD
Zonisamide—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000113	0.000349	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PLCG1—sarcoma	0.000111	0.000344	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—KRAS—sarcoma	0.000111	0.000342	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—KRAS—sarcoma	0.000111	0.000342	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ENO2—sarcoma	0.00011	0.000342	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—CTNNB1—sarcoma	0.00011	0.00034	CbGpPWpGaD
Zonisamide—CA9—Metabolism—HBA1—sarcoma	0.00011	0.00034	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—SRC—sarcoma	0.000109	0.000338	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—HRAS—sarcoma	0.000108	0.000333	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—KRAS—sarcoma	0.000107	0.00033	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PLCG1—sarcoma	0.000107	0.00033	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—VEGFA—sarcoma	0.000106	0.000329	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—SRC—sarcoma	0.000106	0.000327	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—CTNNB1—sarcoma	0.000105	0.000327	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—CTNNB1—sarcoma	0.000105	0.000327	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—NRAS—sarcoma	0.000105	0.000325	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PLCG1—sarcoma	0.000104	0.000323	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—HRAS—sarcoma	0.000104	0.000323	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—HRAS—sarcoma	0.000104	0.000322	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ENO2—sarcoma	0.000104	0.000322	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—SRC—sarcoma	0.000104	0.000321	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—HBA1—sarcoma	0.000103	0.00032	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—VEGFA—sarcoma	0.000103	0.000319	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—HRAS—sarcoma	0.000102	0.000317	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—CTNNB1—sarcoma	0.000102	0.000315	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—NRAS—sarcoma	0.000102	0.000315	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—VEGFA—sarcoma	0.000101	0.000313	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—CREB1—sarcoma	0.0001	0.00031	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—NRAS—sarcoma	9.98e-05	0.000309	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—SRC—sarcoma	9.92e-05	0.000307	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—HRAS—sarcoma	9.87e-05	0.000306	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—HRAS—sarcoma	9.79e-05	0.000303	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—VEGFA—sarcoma	9.67e-05	0.000299	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—EGFR—sarcoma	9.56e-05	0.000296	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—NRAS—sarcoma	9.55e-05	0.000296	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—SRC—sarcoma	9.53e-05	0.000295	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—SRC—sarcoma	9.53e-05	0.000295	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—TP53—sarcoma	9.5e-05	0.000294	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—HRAS—sarcoma	9.4e-05	0.000291	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—HRAS—sarcoma	9.4e-05	0.000291	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—MDM2—sarcoma	9.37e-05	0.00029	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PLCG1—sarcoma	9.37e-05	0.00029	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MMP2—sarcoma	9.33e-05	0.000289	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—VEGFA—sarcoma	9.29e-05	0.000287	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—VEGFA—sarcoma	9.29e-05	0.000287	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—EGFR—sarcoma	9.26e-05	0.000287	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—SRC—sarcoma	9.19e-05	0.000285	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—NRAS—sarcoma	9.17e-05	0.000284	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—NRAS—sarcoma	9.17e-05	0.000284	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—EGFR—sarcoma	9.09e-05	0.000282	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—HRAS—sarcoma	9.07e-05	0.000281	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—SRC—sarcoma	9.06e-05	0.00028	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—KRAS—sarcoma	9.03e-05	0.00028	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—VEGFA—sarcoma	8.95e-05	0.000277	CbGpPWpGaD
Zonisamide—AOX1—Disease—FOXO1—sarcoma	8.85e-05	0.000274	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—NRAS—sarcoma	8.84e-05	0.000274	CbGpPWpGaD
Zonisamide—AOX1—Disease—PDGFRB—sarcoma	8.84e-05	0.000274	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PLCG1—sarcoma	8.83e-05	0.000273	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—VEGFA—sarcoma	8.82e-05	0.000273	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—KRAS—sarcoma	8.75e-05	0.000271	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—NRAS—sarcoma	8.71e-05	0.00027	CbGpPWpGaD
Zonisamide—AOX1—Disease—PDGFRA—sarcoma	8.7e-05	0.000269	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—EGFR—sarcoma	8.7e-05	0.000269	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—KRAS—sarcoma	8.59e-05	0.000266	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—EGFR—sarcoma	8.36e-05	0.000259	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—EGFR—sarcoma	8.36e-05	0.000259	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—KRAS—sarcoma	8.22e-05	0.000254	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—EGFR—sarcoma	8.06e-05	0.000249	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—EGFR—sarcoma	7.94e-05	0.000246	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—KRAS—sarcoma	7.89e-05	0.000244	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—KRAS—sarcoma	7.89e-05	0.000244	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—HRAS—sarcoma	7.68e-05	0.000238	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—KRAS—sarcoma	7.61e-05	0.000236	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—KRAS—sarcoma	7.5e-05	0.000232	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—HRAS—sarcoma	7.43e-05	0.00023	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—HRAS—sarcoma	7.3e-05	0.000226	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—CTNNB1—sarcoma	7.15e-05	0.000221	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—HRAS—sarcoma	6.98e-05	0.000216	CbGpPWpGaD
Zonisamide—AOX1—Disease—KIT—sarcoma	6.74e-05	0.000209	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—HRAS—sarcoma	6.71e-05	0.000208	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—HRAS—sarcoma	6.71e-05	0.000208	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—HRAS—sarcoma	6.71e-05	0.000208	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ENO2—sarcoma	6.53e-05	0.000202	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—HBA1—sarcoma	6.49e-05	0.000201	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—HRAS—sarcoma	6.47e-05	0.0002	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—SRC—sarcoma	6.46e-05	0.0002	CbGpPWpGaD
Zonisamide—AOX1—Disease—CREB1—sarcoma	6.42e-05	0.000199	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—HRAS—sarcoma	6.37e-05	0.000197	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—VEGFA—sarcoma	6.29e-05	0.000195	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—NRAS—sarcoma	6.22e-05	0.000192	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—EGFR—sarcoma	5.66e-05	0.000175	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PLCG1—sarcoma	5.54e-05	0.000171	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—KRAS—sarcoma	5.35e-05	0.000166	CbGpPWpGaD
Zonisamide—AOX1—Disease—MDM2—sarcoma	5.31e-05	0.000164	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—HRAS—sarcoma	5.14e-05	0.000159	CbGpPWpGaD
Zonisamide—AOX1—Disease—CTNNB1—sarcoma	4.58e-05	0.000142	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—HRAS—sarcoma	4.55e-05	0.000141	CbGpPWpGaD
Zonisamide—AOX1—Disease—SRC—sarcoma	4.14e-05	0.000128	CbGpPWpGaD
Zonisamide—AOX1—Disease—NRAS—sarcoma	3.98e-05	0.000123	CbGpPWpGaD
Zonisamide—AOX1—Disease—MYC—sarcoma	3.71e-05	0.000115	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGFR—sarcoma	3.63e-05	0.000112	CbGpPWpGaD
Zonisamide—AOX1—Disease—KRAS—sarcoma	3.43e-05	0.000106	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ENO2—sarcoma	3.09e-05	9.57e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HBA1—sarcoma	3.07e-05	9.51e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—HRAS—sarcoma	2.91e-05	9.02e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PLCG1—sarcoma	2.62e-05	8.12e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ENO2—sarcoma	1.86e-05	5.75e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HBA1—sarcoma	1.85e-05	5.72e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PLCG1—sarcoma	1.58e-05	4.88e-05	CbGpPWpGaD
